ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,56
0,02%
Bitcoin
58 886,96
1,11%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Mustang Bio Inc (MBIO)

  7. Mustang Bio Inc (MBIO) Actualités

MBIO Mustang Bio Inc

0,2838
0,0237 (9,11%)
Après les heures de négociation
Dernière mise à jour : 22:59:57
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mustang Bio Inc MBIO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0237 9,11% 0,2838 22:59:57
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,2699 0,2699 0,2999 0,293 0,2601
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
30/4/202402:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
28/3/202414:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
11/3/202421:30EDGAR2Form 8-K - Current report
11/3/202421:05GLOBEMustang Bio Reports Full-Year 2023 Financial Results and..
11/3/202421:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
14/2/202422:15EDGAR2Form 8-K - Current report
25/1/202422:07EDGAR2Form 8-K - Current report
11/1/202414:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
04/1/202422:05EDGAR2Form 8-K - Current report
19/12/202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202303:52EDGAR2Form S-1 - General form for registration of securities under..
11/12/202314:37EDGAR2Form 8-K - Current report
11/12/202314:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
14/11/202322:44EDGAR2Form 8-K - Current report
14/11/202322:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
03/11/202320:22EDGAR2Form D - Notice of Exempt Offering of Securities
02/11/202321:05EDGAR2Form 8-K - Current report
02/11/202314:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
30/10/202319:57EDGAR2Form 8-K - Current report
30/10/202319:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
30/10/202315:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/10/202322:05EDGAR2Form 8-K - Current report
26/10/202318:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
26/10/202315:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
04/10/202322:05EDGAR2Form 8-K - Current report
16/8/202314:56EDGAR2Form 8-K - Current report
14/8/202322:10EDGAR2Form 8-K - Current report
14/8/202322:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
14/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202314:40EDGAR2Form 8-K - Current report
20/7/202323:30EDGAR2Form 8-K - Current report
11/7/202314:05EDGAR2Form 8-K - Current report
07/7/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202314:05EDGAR2Form 8-K - Current report
15/5/202322:01GLOBEFortress Biotech Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
MBIO
Mustang Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés